Journal article · 2021 · Open access
CCR7+ dendritic cells sorted by binding of CCL19 show enhanced Ag-presenting capacity and antitumor potency
Journal of Leukocyte Biology, 111(6), 1243–1251 · Published 15 November 2021 · DOI 10.1002/jlb.5ab0720-446rr
In brief
“CCR7+ dendritic cells sorted by binding of CCL19 show enhanced Ag-presenting capacity and antitumor potency” is a 2021 journal article by Paul Burgoyne and 6 co-authors, published in Journal of Leukocyte Biology. OpenAlex counts 10 citations as of 18 November 2026. It is open access under a CC BY licence: the full text is free to read at Journal of Leukocyte Biology.
- Citations
- 10
- Most cited in
- 2026 (4)
- Field-weighted impact
- 0.44
- References
- 28
- Authors
- 7
Abstract
Dendritic cell therapy has been a promising addition to the current armory of therapeutic options in cancer for more than 20 years but has not yet achieved breakthrough success. To successfully initiate immunity, dendritic cells have to enter the lymph nodes. However, experience to date of therapeutic dendritic cell administration indicates that this is frequently an extremely inefficient process. The major regulator of dendritic cell migration to the lymph nodes is the chemokine receptor CCR7 and in vitro generated dendritic cells typically display heterogeneous expression of this receptor. Here we demonstrate that positive selection for the dendritic cell subpopulation expressing CCR7, using a chemically-synthesized ligand:CCL19, enriches for cells with enhanced lymph node migration and Ag presentation competence as well as a chemokine expression profile indicative of improved interactions with T cells. This enhanced lymph node homing capacity of enriched CCR7+ cells is seen in comparison to a population of unsorted dendritic cells containing an equivalent number of CCR7+ dendritic cells. Importantly, this indicates that separating the CCR7+ dendritic cells from the CCR7- cells, rather than simple CCL19 exposure, is required to affect the enhanced lymph node migration of the CCR7+ cells. In models of both subcutaneous and metastatic melanoma, we demonstrate that the dendritic cells sorted for CCR7 expression trigger enhanced CD8 T-cell driven antitumor immune responses which correlate with reduced tumor burden and increased survival. Finally, we demonstrate that this approach is directly translatable to human dendritic cell therapy using the same reagents coupled with clinical-grade flow-cytometric sorting.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Burgoyne, P., Hayes, A. J., Cooper, R. S., Le Brocq, M. L., Hansell, C. A., Campbell, J. D. M., & Graham, G. J. (2021). CCR7+ dendritic cells sorted by binding of CCL19 show enhanced Ag-presenting capacity and antitumor potency. Journal of Leukocyte Biology, 111(6), 1243–1251. https://doi.org/10.1002/jlb.5ab0720-446rr
MLA 9
Burgoyne, Paul, et al. “CCR7+ dendritic cells sorted by binding of CCL19 show enhanced Ag-presenting capacity and antitumor potency.” Journal of Leukocyte Biology, vol. 111, no. 6, 2021, pp. 1243–1251. https://doi.org/10.1002/jlb.5ab0720-446rr.
Chicago
Burgoyne, Paul, Alan James Hayes, Rachel S. Cooper, Michelle L. Le Brocq, Christopher A.H. Hansell, John D. M. Campbell, and Gerard J. Graham. 2021. “CCR7+ dendritic cells sorted by binding of CCL19 show enhanced Ag-presenting capacity and antitumor potency.” Journal of Leukocyte Biology 111 (6): 1243–1251. https://doi.org/10.1002/jlb.5ab0720-446rr.
Harvard
Burgoyne, P. et al. (2021) ‘CCR7+ dendritic cells sorted by binding of CCL19 show enhanced Ag-presenting capacity and antitumor potency’, Journal of Leukocyte Biology, 111(6), pp. 1243–1251. doi:10.1002/jlb.5ab0720-446rr.
IEEE
P. Burgoyne et al., “CCR7+ dendritic cells sorted by binding of CCL19 show enhanced Ag-presenting capacity and antitumor potency,” Journal of Leukocyte Biology, vol. 111, no. 6, pp. 1243–1251, 2021, doi: 10.1002/jlb.5ab0720-446rr.
BibTeX
@article{burgoyne2021dendritic,
title = {{CCR7+ dendritic cells sorted by binding of CCL19 show enhanced Ag-presenting capacity and antitumor potency}},
author = {Burgoyne, Paul and Hayes, Alan James and Cooper, Rachel S. and Le Brocq, Michelle L. and Hansell, Christopher A.H. and Campbell, John D. M. and Graham, Gerard J.},
journal = {Journal of Leukocyte Biology},
year = {2021},
volume = {111},
number = {6},
pages = {1243--1251},
doi = {10.1002/jlb.5ab0720-446rr},
url = {https://doi.org/10.1002/jlb.5ab0720-446rr}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 1 | |
| 2023 | 3 | |
| 2024 | 1 | |
| 2025 | 1 | |
| 2026 | 4 |
Its field-weighted citation impact is 0.44: it has been cited 0.44 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- dendritic cell immunotherapy
- CCR7
- CCL19
- dendritic cell migration
- lymph node homing
- antigen presentation
- positive selection
- chemokine expression
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Burgoyne, P., Hayes, A. J., Cooper, R. S., Le Brocq, M. L., Hansell, C. A., Campbell, J. D. M., & Graham, G. J. (2021). CCR7+ dendritic cells sorted by binding of CCL19 show enhanced Ag-presenting capacity and antitumor potency. Journal of Leukocyte Biology, 111(6), 1243–1251. https://doi.org/10.1002/jlb.5ab0720-446rr
How many times has this paper been cited?
10 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Leukocyte Biology: sign in and open the PDF from this page.
Who wrote this paper?
Paul Burgoyne, Alan James Hayes, Rachel S. Cooper, Michelle L. Le Brocq, Christopher A.H. Hansell, John D. M. Campbell, Gerard J. Graham.
What is the DOI of this paper?
10.1002/jlb.5ab0720-446rr, permanently at https://doi.org/10.1002/jlb.5ab0720-446rr. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.